Improved diabetic syndrome in C57BL/KsJ‐db/db mice by oral administration of the Na⁺‐glucose cotransporter inhibitor T‐1095

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)

1998 • 19,638 citations

Dietary Advanced Glycation End Products and Their Potential Role in Cardiometabolic Disease in Children

2016 • 3,967 citations

Pathogenesis of NIDDM: A Balanced Overview

1992 • 2,111 citations

Diabetes, a New Mutation in the Mouse

1966 • 966 citations

Hyperglycemie and Microvascular and Macrovascular Disease in Diabetes

1995 • 861 citations

Glucose Toxicity

1990 • 742 citations

Effect of intensive therapy on the development and progression of diabetic nephropathy in the Diabetes Control and Complications Trial

1995 • 666 citations

Hyperglycaemia as an inducer as well as a consequence of impaired islet cell function and insulin resistance: implications for the management of diabetes

1985 • 461 citations

Laboratory animals exhibiting obesity and diabetes syndromes

1977 • 417 citations

Glucagon physiology and pathophysiology in the light of new advances

1985 • 360 citations

Insulin Resistance or Insulin Deficiency: Which Is the Primary Cause of NIDDM?

1994 • 297 citations

T-1095, an inhibitor of renal Na+-glucose cotransporters, may provide a novel approach to treating diabetes.

1999 • 245 citations

Preservation of insulin mRNA levels and insulin secretion in HIT cells by avoidance of chronic exposure to high glucose concentrations.

1992 • 233 citations

Glycemic improvement in diabetic db/db mice by overexpression of the human insulin-regulatable glucose transporter (GLUT4).

1995 • 220 citations

Diabetes Complications: Why Is Glucose Potentially Toxic?

1996 • 205 citations

A rapid method for the isolation of kidney brush border membranes

1979 • 196 citations

Prediction of Clinical Diabetic Nephropathy in IDDM Patients: Alternatives to Microalbuminuria?

1990 • 169 citations

STRUCTURE AND FUNCTION OF HEXOSE TRANSPORTERS

1991 • 165 citations

Prevention of Diabetic Nephropathy by Diet Control in the db/db Mouse

1981 • 145 citations

Improved Glucose Tolerance Restores Insulin-Stimulated Akt Kinase Activity and Glucose Transport in Skeletal Muscle From Diabetic Goto-Kakizaki Rats

1997 • 138 citations

Na⁺-Glucose Cotransporter (SGLT) Inhibitors as Antidiabetic Agents. 4. Synthesis and Pharmacological Properties of 4‘-Dehydroxyphlorizin Derivatives Substituted on the B Ring

1999 • 120 citations

Characterization of CS-045, a new oral antidiabetic agent, II. Effects on glycemic control and pancreatic islet structure at a late stage of the diabetic syndrome in mice

1991 • 118 citations

Long Term Effects of Aminoguanidine on Insulin Release and Biosynthesis: Evidence That the Formation of Advanced Glycosylation End Products Inhibits B Cell Function¹

1997 • 109 citations

Phlorizin hydrolase: A β-glucosidase of hamster intestinal brush border membrane

1969 • 103 citations

Na+-Glucose Cotransporter Inhibitors as Antidiabetics. I. Synthesis and Pharmacological Properties of 4'-Dehydroxyphlorizin Derivatives Based on a New Concept.

1996 • 90 citations

Glucose toxicity: the implications of hyperglycemia in the pathophysiology of diabetes mellitus.

1995 • 88 citations

Glucose transporters of the glomerulus and the implications for diabetic nephropathy.

1997 • 76 citations

Hyperglycemia contributes insulin resistance in hepatic and adipose tissue but not skeletal muscle of ZDF rats

2000 • 73 citations

Association of immune mediators at diagnosis of Type 1 diabetes with later clinical remission

2007 • 70 citations

Amelioration of diabetic nephropathy by treatment with monoclonal antibodies against glycated albumin

1994 • 60 citations

DEVELOPMENT OF THE INSULIN SECRETORY DEFECT IN GENETICALLY DIABETIC (db/db) MOUSE

1978 • 60 citations

Insulin resistance in rats with non-insulin-dependent diabetes induced by neonatal (5 days) streptozotocin: Evidence for reversal following phlorizin treatment

1990 • 59 citations

Antidiabetic effect of T-1095, an inhibitor of Na+-glucose cotransporter, in neonatally streptozotocin-treated rats

2000 • 58 citations

The Effect of Chronic α-Glycosidase Inhibition on Diabetic Nephropathy in the db/db Mouse

1982 • 38 citations

Long Term Effects of Aminoguanidine on Insulin Release and Biosynthesis: Evidence That the Formation of Advanced Glycosylation End Products Inhibits B Cell Function

1997 • 36 citations

Hyperglycemia Impairs the Insulin Signaling Step between PI 3-Kinase and Akt/PKB Activations in ZDF Rat Liver

1999 • 36 citations

Na+-Glucose Cotransporter Inhibitors as Antidiabetic Agents. II. Synthesis and Structure-Activity Relationships of 4'-Dehydroxyphlorizin Derivatives.

1998 • 33 citations

Potential benefit of inhibitors of advanced glycation end products in the progression of type II diabetes: A study with aminoguanidine in C57/BLKsJ diabetic mice

1998 • 28 citations

Na+-Glucose Cotransporter Inhibitors as Antidiabetic Agents. III. Synthesis and Pharmacological Properties of 4'-Dehydroxyphlorizin Derivatives Modified at the OH Groups of the Glucose Moiety.

1998 • 21 citations

ChemInform Abstract: Na⁺‐Glucose Cotransporter (SGLT) Inhibitors as Antidiabetic Agents. Part 4. Synthesis and Pharmacological Properties of 4′‐Dehydroxyphlorizin Derivatives Substituted on the B Ring.

2000 • 19 citations

Evidence that increased glucose cycling in islets of diabetic ob/ob mice is a primary feature of the disease

1995 • 17 citations